Cancer cells can evade such a response, as they activate pyruvate dehydrogenase kinase 1 (PDK1) or inhibit pyruvate dehydrogenase phosphatase catalytic subunit 2 (PDP2), resulting in limited pyruvate utilization by mitochondria and reduced ROS production59. Here, PDP2 is linked to cancer.